Ligand Pharmaceuticals Inc (LGND)
112.70
-2.75
(-2.38%)
USD |
NASDAQ |
Nov 15, 11:16
Ligand Pharmaceuticals Net Income (TTM): 45.24M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 45.24M |
June 30, 2024 | 42.14M |
March 31, 2024 | 96.34M |
December 31, 2023 | 52.15M |
September 30, 2023 | 16.48M |
June 30, 2023 | 27.16M |
March 31, 2023 | 23.97M |
December 31, 2022 | -33.36M |
September 30, 2022 | -21.29M |
June 30, 2022 | -7.973M |
March 31, 2022 | 23.65M |
December 31, 2021 | 57.14M |
September 30, 2021 | 68.32M |
June 30, 2021 | 47.89M |
March 31, 2021 | 39.25M |
December 31, 2020 | -2.985M |
September 30, 2020 | -16.11M |
June 30, 2020 | -24.66M |
March 31, 2020 | -61.17M |
December 31, 2019 | 629.30M |
September 30, 2019 | 594.18M |
June 30, 2019 | 676.80M |
March 31, 2019 | 764.38M |
December 31, 2018 | 143.32M |
September 30, 2018 | 178.79M |
Date | Value |
---|---|
June 30, 2018 | 119.86M |
March 31, 2018 | 52.75M |
December 31, 2017 | 12.55M |
September 30, 2017 | 16.44M |
June 30, 2017 | 9.062M |
March 31, 2017 | -3.166M |
December 31, 2016 | -1.637M |
September 30, 2016 | 7.83M |
June 30, 2016 | 205.94M |
March 31, 2016 | 235.68M |
December 31, 2015 | 229.82M |
September 30, 2015 | 230.54M |
June 30, 2015 | 32.65M |
March 31, 2015 | 10.68M |
December 31, 2014 | 12.02M |
September 30, 2014 | 6.838M |
June 30, 2014 | 7.523M |
March 31, 2014 | 12.02M |
December 31, 2013 | 11.42M |
September 30, 2013 | 10.61M |
June 30, 2013 | 8.455M |
March 31, 2013 | -0.165M |
December 31, 2012 | -0.527M |
September 30, 2012 | 3.096M |
June 30, 2012 | -0.888M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-61.17M
Minimum
Mar 2020
629.30M
Maximum
Dec 2019
50.07M
Average
25.57M
Median
Net Income (TTM) Benchmarks
Regeneron Pharmaceuticals Inc | 4.654B |
Agios Pharmaceuticals Inc | 674.31M |
ADMA Biologics Inc | 68.13M |
Pieris Pharmaceuticals Inc | -23.82M |
AnaptysBio Inc | -165.66M |